Hologic Falls After Q4 Beat, Weak Guidance

Hologic (NASDAQ: HOLX ) reported positive fourth quarter results Monday, but they were not enough to stop investors from selling the stock. The medical imaging systems company, which also manufactures diagnostic and surgical products, was down more than seven percent in after hours trading, thanks to Q1 EPS guidance of